Automated quantification of SARS-CoV-2 pneumonia with large vision model knowledge adaptation
- PMID: 39253407
- PMCID: PMC11381763
- DOI: 10.1016/j.nmni.2024.101457
Automated quantification of SARS-CoV-2 pneumonia with large vision model knowledge adaptation
Abstract
Background: Large vision models (LVM) pretrained by large datasets have demonstrated their enormous capacity to understand visual patterns and capture semantic information from images. We proposed a novel method of knowledge domain adaptation with pretrained LVM for a low-cost artificial intelligence (AI) model to quantify the severity of SARS-CoV-2 pneumonia based on frontal chest X-ray (CXR) images.
Methods: Our method used the pretrained LVMs as the primary feature extractor and self-supervised contrastive learning for domain adaptation. An encoder with a 2048-dimensional feature vector output was first trained by self-supervised learning for knowledge domain adaptation. Then a multi-layer perceptron (MLP) was trained for the final severity prediction. A dataset with 2599 CXR images was used for model training and evaluation.
Results: The model based on the pretrained vision transformer (ViT) and self-supervised learning achieved the best performance in cross validation, with mean squared error (MSE) of 23.83 (95 % CI 22.67-25.00) and mean absolute error (MAE) of 3.64 (95 % CI 3.54-3.73). Its prediction correlation has the of 0.81 (95 % CI 0.79-0.82) and Spearman ρ of 0.80 (95 % CI 0.77-0.81), which are comparable to the current state-of-the-art (SOTA) methods trained by much larger CXR datasets.
Conclusion: The proposed new method has achieved the SOTA performance to quantify the severity of SARS-CoV-2 pneumonia at a significantly lower cost. The method can be extended to other infectious disease detection or quantification to expedite the application of AI in medical research.
Keywords: Artificial intelligence; Large vision model; SARS-CoV2 pneumonia; Self-supervised learning; Vision transformer.
Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- WHO, WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int/, last accessed 2024/July/10.
-
- National Institutes of Health. NIH covid-19 treatment guidelines. Clinical spectrum of SARS-CoV-2 Infection. 2020. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum, last accessed 2024/December/27.
-
- Attaway A.H., Scheraga R.G., Bhimraj A., Biehl M., Hatipoglu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 2021 Mar 10;372 - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous